Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial / Maria Boesing, Kristin Abig, Michael Brändle, Martin Brutsche, Emanuel Burri, Björn C. Frye, Stéphanie Giezendanner, Jan C. Grutters, Philippe Haas, Justian Heisler, Fabienne Jaun, Anne B. Leuppi-Taegtmeyer, Giorgia Lüthi-Corridori, Joachim Müller-Quernheim, Reto Nüesch, Wolfgang Pohl, Frank Rassouli, Jörg D. Leuppi
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
London: BioMed Central ; 2022 Freiburg: Albert-Ludwigs-Universität Freiburg ; 2022 |
| Enthalten in: |
Trials - 23, 1 (2022), 790 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Boesing, Maria [VerfasserIn] |
|---|
| Links: |
nbn-resolving.de [kostenfrei] |
|---|
| Umfang: |
1 Online-Ressource (13 Seiten) ; Diagramme ; Supplementary information |
|---|
| doi: |
10.1186/s13063-022-06723-w |
|---|---|
| Weitere IDs: |
urn:nbn:de:bsz:25-freidok-2301450 FRUB-opus-230145 |
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1830354507 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1830354507 | ||
| 003 | DE-627 | ||
| 005 | 20230427151606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230104s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a urn:nbn:de:bsz:25-freidok-2301450 |2 urn | |
| 024 | 7 | |a 10.1186/s13063-022-06723-w |2 doi | |
| 024 | 8 | |a FRUB-opus-230145 |q Opus Nr. | |
| 035 | |a (DE-627)1830354507 | ||
| 035 | |a (DE-599)KXP1830354507 | ||
| 035 | |a (OCoLC)1356995966 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DE-101 |
| 100 | 1 | |a Boesing, Maria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial |c Maria Boesing, Kristin Abig, Michael Brändle, Martin Brutsche, Emanuel Burri, Björn C. Frye, Stéphanie Giezendanner, Jan C. Grutters, Philippe Haas, Justian Heisler, Fabienne Jaun, Anne B. Leuppi-Taegtmeyer, Giorgia Lüthi-Corridori, Joachim Müller-Quernheim, Reto Nüesch, Wolfgang Pohl, Frank Rassouli, Jörg D. Leuppi |
| 264 | 1 | |a London |b BioMed Central |c 2022 | |
| 264 | 2 | |a Freiburg |b Albert-Ludwigs-Universität Freiburg |c 2022 | |
| 300 | |a 1 Online-Ressource (13 Seiten) |b Diagramme |e Supplementary information | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |e Controlled Vocabulary for Access Rights |f Unrestricted online access |u http://purl.org/coar/access_right/c_abf2 |2 star | |
| 700 | 1 | |a Abig, Kristin |e verfasserin |4 aut | |
| 700 | 1 | |a Brändle, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Brutsche, Martin |d 1964- |e verfasserin |0 (DE-588)1089795505 |0 (DE-627)853607958 |0 (DE-576)460543210 |4 aut | |
| 700 | 1 | |a Burri, Emanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Frye, Björn Christian |d 1977- |e verfasserin |0 (DE-588)130115835 |0 (DE-627)490868479 |0 (DE-576)298006332 |4 aut | |
| 700 | 1 | |a Giezendanner, Stéphanie |e verfasserin |4 aut | |
| 700 | 1 | |a Grutters, Jan C. |e verfasserin |4 aut | |
| 700 | 1 | |a Haas, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Heisler, Justian |e verfasserin |4 aut | |
| 700 | 1 | |a Jaun, Fabienne |e verfasserin |4 aut | |
| 700 | 1 | |a Taegtmeyer, Anne B. |e verfasserin |0 (DE-588)1080062475 |0 (DE-627)843633891 |0 (DE-576)453305806 |4 aut | |
| 700 | 1 | |a Lüthi-Corridori, Giorgia |e verfasserin |0 (DE-627)1830354442 |4 aut | |
| 700 | 1 | |a Müller-Quernheim, Joachim |d 1953- |e verfasserin |0 (DE-588)1104394766 |0 (DE-627)861818075 |0 (DE-576)470962496 |4 aut | |
| 700 | 1 | |a Nüesch, Reto |e verfasserin |4 aut | |
| 700 | 1 | |a Pohl, Wolfgang |e verfasserin |4 aut | |
| 700 | 1 | |a Rassouli, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Leuppi, Jörg D. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Sonderdruck aus |t Trials |g 23, 1 (2022), 790 |x 1745-6215 |
| 856 | 4 | 0 | |u https://nbn-resolving.de/urn:nbn:de:bsz:25-freidok-2301450 |q application/pdf |x Resolving-System |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s13063-022-06723-w |x Resolving-System |z kostenfrei |
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_2403 | ||
| 912 | |a ISIL_DE-LFER | ||
| 935 | |c so | ||
| 951 | |a BO | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 4244166041 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |k Elektronischer Volltext - Zugang über WWW |y l01 |z 04-01-23 | ||
| 980 | |2 2403 |1 01 |x DE-LFER |b 4248164248 |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |y l01 |z 15-01-23 | ||
| 981 | |2 2003 |1 01 |x DE-25 |r http://nbn-resolving.de/urn:nbn:de:bsz:25-freidok-2301450 | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r https://doi.org/10.1186/s13063-022-06723-w | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r https://nbn-resolving.de/urn:nbn:de:bsz:25-freidok-2301450 | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 00 |s s |a Pharmacology (medical) | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 01 |s s |a Medicine (miscellaneous) | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 02 |s s |a Aviptadil | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 03 |s s |a VIP | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 04 |s s |a COVID-19 | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 05 |s s |a ARDS | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 06 |s s |a SARS-CoV-2 | ||